Efficacy of Kera Sol Tears on Signs and Symptoms of Surgical Temporary Ocular Discomfort Syndrome (STODS) in Subjects Following LASIK

Part of paid clinical trials in Sioux Falls, South Dakota.

Sponsor
Vance Thompson Vision
Study ID
NCT07155070
Phase
PHASE4
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Kera Sol Eye Drops — DRUG
    Eye drops

Study Details

Collecting data using Kera Sol tear usage during the initial two-week post-operative period after Laser-Assisted In Situ Keratomileusis (LASIK) has on the signs and symptoms of surgical temporary ocular discomfort syndrome (STODS)

Key Dates

Start date
Aug 1, 2025
Status verified
Sep 2025
Primary completion
Dec 30, 2025
Completion
Feb 1, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Active Comparator: Kera Sol
    Subjects will be randomized to administer the study drop (Kera Sol) dosed QID for 14 days.
  • No Intervention: Standard of Care
    No Kera Sol drops

Primary Outcome Measure

Change in Baseline of Corneal Staining [ Time Frame: 14 days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vance Thompson Vision Clinic, Prof. LLCSioux FallsSouth Dakota57108
Tiffany Facile
605-371-7075

Find similar trials in Sioux Falls, SD

Related Studies